Oncology Drugs Market Research Report, Growth & Forecast

... Cancer Tyrosine Kinase Inhibitors Signaling Pathway of Receptor Tyrosine Kinase Advantage of Tyrosine Kinase Inhibitors for Treatment of Cancer Applications of Tyrosine Kinase Inhibitor in Cancer Therapy Global Tyrosine Kinase Inhibitors Market Overview Global Cancer Tyrosine Kinase Inhibitors ...

... Angiogenesis Inhibitors Metronomic Therapy - A Recent Advancement in Anti-Angiogenesis Therapy Global Cancer Angiogenesis Inhibitors Clinical Pipeline by Company, Indication & Phase Global Cancer Angiogenesis Inhibitors Clinical Pipeline: 146 Drugs Marketed Cancer Angiogenesis Inhibitors Drugs: 11 Drugs ...

... Immunotoxins to Multiple Cancer Therapies Global Cancer Immunotoxins Market Future Prospects Global Cancer Immunotoxins Clinical Pipeline by Company, Indication & Phase Global Cancer Immunotoxins Clinical Pipeline: 52 Cancer Immunotoxins Majority Cancer Immunotoxins ...

... Global Malignant Melanoma Drug Market & Clinical Pipeline Insight” Report Highlight: Global Malignant Melanoma Market Analysis Malignant Melanoma Drug Mechanism of Action Global Malignant Melanoma Clinical Pipeline By Company & Phase Global Malignant Melanoma Clinical Pipeline: 201 Drugs Majority Malignant ...

... Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015” Report Highlight: Nomenclature & Classification of CD Antigens Mechanism of CD Antigen Cancer Therapeutics Cancer CD Antigen Therapy Market Overview Cancer CD Antigen Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer ...

... Breast Cancer Incidence & Prevalence US Breast Cancer Therapy Market Overview US Breast Cancer Drug Clinical Pipeline by Company & Phase US Breast Cancer Drug Clinical Pipeline: 251 Drugs Majority Drugs in Phase-II Trials: 73 Drugs Marketed Breast Cancer Drugs in US: 32 Drugs Breast Cancer ...

... & Prevalence Blood Cancer Drug Market Overview Blood Cancer Drug Market Dynamics Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline Insight Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline: 435 Drugs Majority Drugs in Phase-I Clinical Trials: 128 Drugs Marketed Leukemia, Lymphoma & Myeloma Drug Clinical ...

... Monoclonal Antibodies, Vaccines 'Global Cancer Immunotherapy Market Outlook 2020' Report Highlight: Introduction & Classification of Cancer Immunotherapy Global Cancer Immunotherapy Pipeline by Company, Indication & Phase Marketed Cancer Immunotherapies ...

... Oncogene Inhibitors Pipeline: 185 Drugs Majority Oncogene Inhibitors in Preclinical Phase: 105 Drugs Proto Oncogene Protein c met Inhibitors Pipeline: 42 Drugs Proto Oncogene Protein c-akt Inhibitors: 39 Drugs Marketed Oncogene Inhibitors: 22 Drugs Marketed Proto-Oncogene Protein c-bcl-2 Inhibitors: 8 Drugs ...

... Tyrosine Kinase Therapeutics Global Tyrosine Kinase Inhibitors Pipeline by Company, Indication & Phase Global Tyrosine Kinase Inhibitors Pipeline: 557 Drugs Majority Drugs in Preclinical Phase: 239 Drugs Marketed Tyrosine Kinase Inhibitors: 58 Drugs Marketed Tyrosine Kinase Inhibitors ...

... Cancer Targeted Therapy Market & Clinical Insight” Report Highlight: Introduction & Categorization of Cancer Targeted Therapies Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies Cancer Targeted Therapy ...

... Cancer Growth Inhibitors Cancer Growth Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer Growth Inhibitors Clinical Pipeline: 629 Drugs Markets Cancer Growth Inhibitors: 48 Drugs Tyrosine Kinase Dominates Cancer Growth Inhibitors Pipeline: 394 Drugs HDAC Inhibitors Clinical Pipeline: 65 Drugs ...

... Non Small Cell Lung Cancer Market & Pipeline Insight” Report Highlights: NSCLC Therapy Market Overview Mechanism of NSCLC Therapeutics NSCLC Therapy Market Dynamics: Drivers, Challenges & Future Prospects) NSCLC Drug Pipeline ...

... Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview Mechanism of Non Hodgkin Lymphoma Therapeutics Global Non Hodgkin Lymphoma Pipeline by Type, Phase & Company Global Non Hodgkin Lymphoma Pipeline ...

... Cancer Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country Cancer Monoclonal Antibodies in Pipeline: 605 Majority Cancer Monoclonal Antibodies Preclinical Phase: 258 Marketed Cancer Monoclonal Antibodies: 34 Cancer Monoclonal Antibodies ...

... Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase, Indication, Company & Country Marketed Cancer Kinase Inhibitors Therapy ...

... use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: Cancer Immunotherapy Market Overview Cancer Immunotherapy Market Dynamics Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country Cancer Vaccine Clinical ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all cases. It is a malignant tumor that begins in the cells lining the lungs and can spre...

This report will be delivered in 7-10 working days. EGFR (epidermal growth factor receptor) inhibitors are widely used in the treatment of various cancers, including non-small cell lung cancer, head a...

This report will be delivered in 7-10 working days. The global hormone sensitive advanced prostate cancer (HSPC) market is experiencing significant growth, driven by the rising incidence of prostate c...

The global gastric cancer market is projected to grow steadily during the forecast period, driven by the rising global burden of gastric malignancies, increasing cancer screening awareness, and rapid...

Follicular lymphoma is a type of non-Hodgkin lymphoma, which is a cancer that originates in the lymphatic system, specifically in the lymph nodes. It is characterized by the uncontrolled growth of B c...

Epidermal growth factor receptor non-small cell lung cancer is a type of lung cancer characterized by the presence of mutations in the EGFR gene, which leads to the uncontrolled growth of cancer cells...

The global small cell lung cancer (SCLC) market is experiencing considerable expansion, driven by the increasing prevalence of lung cancer, heightened awareness about the condition, and advancements i...

The global acute myeloid leukemia market is experiencing significant growth, driven by increasing advancements in diagnostic technologies, novel treatment options, and a rising understanding of the di...

Biliary tract cancers include intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gallbladder cancer. The introduction of advanced molecular diagnostics and next-generation sequencin...

The global cutaneous squamous cell carcinoma market is poised for significant growth as increasing incidences of skin cancers, and advancements in treatment modalities continue to drive market expansi...

Myelofibrosis (MF) is a rare type of bone marrow cancer in which the bone marrow gradually becomes replaced by fibrous scar tissue, impairing its ability to produce healthy blood cells. This disruptio...

The global astrocytoma market is expected to experience steady growth, reaching significant valuation by 2025, and is projected to expand at a healthy compound annual growth rate (CAGR) from 2025 to 2...

Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive hematologic malignancy originating from precursors of plasmacytoid dendritic cells (pDCs) immune cells involved in antiviral defen...

Chronic lymphocytic leukemia is a type of cancer that primarily affects the white blood cells, known as lymphocytes, which are a crucial part of the immune system. It is characterized by the gradual a...

Angioimmunoblastic T-cell lymphoma is a rare and aggressive form of peripheral T-cell lymphoma, a type of non-Hodgkin lymphoma. It is often characterized by a rapidly progressive course with varied sy...

The global head and neck squamous cell carcinoma market is experiencing steady growth, driven by ongoing advancements in cancer treatment options, increasing awareness of early cancer detection, and t...

Intratumoral cancer therapies refer to treatments that are directly delivered into the tumor itself, rather than through systemic administration (such as oral or intravenous routes). This approach all...

The global rare NRG1 fusion market is expected to witness substantial growth, expanding significantly from 2024 and projected to register a strong compound annual growth rate (CAGR) through 2035. This...

The global soft tissue sarcoma market is projected to witness significant growth, expanding from 2024 to 2035 at a notable compound annual growth rate (CAGR). This growth is mainly driven by the incre...

Multiple myeloma is a rare form of blood cancer that originates in plasma cells, a type of white blood cell responsible for producing antibodies (immunoglobulins) that help the body fight infection. I...

Fallopian tube cancer is a rare type of gynaecologic cancer that begins in the fallopian tubes—the thin tubes that connect the ovaries to the uterus. It usually develops from the epithelial cells lini...

Vulvar cancer is a type of cancer that begins as a growth of abnormal cells on the vulva, which is the area of skin surrounding the urethra and vagina, including the clitoris and labia. It often appea...

Neuroblastoma is a rare and aggressive cancer that primarily affects infants and young children, though it can occur in individuals of any age. It arises from immature nerve cells, called neuroblasts,...

Bone metastasis in solid tumors refers to the spread of cancer cells from their primary site (usually in the lungs, breast, prostate, or other solid tumors) to the bones. This is a common complication...

The global tenosynovial giant cell tumors market is experiencing significant growth due to advancements in targeted therapies and increased awareness of the condition. Tenosynovial giant cell tumors a...

Melanoma is a type of skin cancer that originates in the melanocytes, the cells responsible for producing melanin, the pigment that gives skin its color. It is considered one of the most aggressive fo...

The Global Peripheral T-Cell Lymphoma Market focuses on the management and treatment of peripheral T-cell lymphoma, a rare and aggressive type of non-Hodgkin lymphoma that arises from mature T-cells....

The Global Plexiform Neurofibroma Market focuses on the management and treatment of plexiform neurofibromas, complex benign nerve sheath tumors commonly associated with Neurofibromatosis Type 1 (NF1)....

The global metastatic castration-resistant prostate cancer market is evolving rapidly, driven by the growing aging population and high prevalence of prostate cancer worldwide. With limited curative op...

The global large granular lymphocyte leukemia market is witnessing steady growth driven by increasing awareness of chronic lymphoproliferative disorders, improved hematologic diagnostic techniques, an...

Locally advanced pancreatic cancer is an aggressive, unresectable, non-metastatic tumour involving major blood vessels or regional lymph nodes. Therapeutic approaches include combination chemotherapy...

Low grade serous ovarian carcinoma is a rare epithelial ovarian cancer subtype characterised by slow tumour growth, chemoresistance, and frequent recurrence. Current treatments include surgery, hormon...

The global pancreatic neuroendocrine tumors market is witnessing robust growth, driven by increasing incidence rates of pancreatic malignancies, advancements in diagnostic imaging, and expanding thera...